ALNY Alnylam Pharmaceuticals
$143.82 -2.71%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-2.71%
YTD
-63.80%
P/E
7.27
P/B
66.57
ROE
159.7%
Div yield
—
Beta
0.61
Market cap
$19.8B
RSI (14)
26
Next earnings
Feb 10, 2027
Same sector · Health Care
Compare ALNY with NVO and JNJ →Follow ALNY in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$148.35
Close
$143.82
Day high
$151.41
Day low
$143.40
Volume
2.3M
Latest headlines
Alnylam Pharmaceuticals Expands Sales Force to Accelerate AMVUTTRA Demand
Yahoo Finance · Nov 20
Alnylam to Webcast Presentations at Upcoming December Investor Conferences
Yahoo Finance · Nov 20
Alnylam (ALNY) Stock Looks Undervalued As Shares Fell 68%
Yahoo Finance · Nov 19
Alnylam Pharmaceuticals (ALNY) Stock Dropped, So What Is Driving Attention Now?
Yahoo Finance · Nov 19
Alnylam Collaborator Regeneron Secures FDA Approval of Livsayis™ (cemdisiran), the Seventh FDA-Approved Therapeutic from Alnylam's RNAi Platform in Less Than Nine Years
Yahoo Finance · Nov 19
Alnylam Stock Trades Below Its Pre-$1 Billion Buyback Price
Yahoo Finance · Nov 17
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Nov 5, 2026 View → 10-Q Oct 29, 2026 View → 8-K Oct 29, 2026 View → 10-Q Jul 30, 2026 View → 8-K Jul 30, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell ALNY. Try it in the Lab to size a position and see the risk.